The Assessors of the Asian University Network - Quality Assurance (AUN-QA) are warmly welcomed!
Welcome to the Vietnamese Doctors’ Day!
Research / Publications
Development of an injectable thermosensitive hydrogel depot system for controlled and sustained subcutaneous drug delivery
Home Research Publications Development of an injectable thermosensitive hydrogel depot system for controlled and sustained subcutaneous drug delivery

Development of an injectable thermosensitive hydrogel depot system for controlled and sustained subcutaneous drug delivery

Lam Quoc Vu, Hai Nguyen Thi, Dang Van Thanh, Le thuy Do, Thi Phuong-Quynh Nguyen, Jun-2026, In: International Journal of Pharmaceutics: X, 11, p. 100529

Overview

Abstract:

Arthritis conditions are widely treated with oral nonsteroidal anti-inflammatory drugs, yet long-term therapy is often limited by gastrointestinal toxicity and variable systemic exposure. To overcome these issues, an injectable thermosensitive chitosan/β-cyclodextrin-graft-poly(N-isopropylacrylamide) hydrogel was developed as a subcutaneous depot for sustained diclofenac sodium delivery. The hydrogel was synthesized via free-radical polymerization using glutaraldehyde as a crosslinker. FTIR and 1H NMR confirmed network formation and drug incorporation, while DSC, TGA, and DTG analyses demonstrated enhanced thermal stability. SEM revealed a porous, interconnected structure, and EDX mapping verified uniform drug distribution. Rheological and swelling studies indicated shear-thinning behavior, good injectability at room temperature, rapid sol–gel transition at 37 °C, and reversible temperature-responsive swelling. In vitro release, with profiles best fitted by the Korsmeyer–Peppas model, indicating a non-Fickian diffusion–relaxation mechanism. Enzymatic degradation confirmed sufficient structural stability to support drug release for more than 10 days. HET-CAM and hemolysis assays demonstrated good biocompatibility. In vivo studies showed reduced peak plasma concentration, prolonged Tmax, mean residence time, and half-life, with an approximately three-fold increase in relative bioavailability compared with the control, supporting depot-like sustained release. Overall, this thermosensitive hydrogel represents a promising platform for controlled and sustained subcutaneous drug delivery.

Keyword(s): Injectable thermosensitive hydrogel; Controlled and sustained release; Ininvivo pharmacokinetic

Article number 100529
Journal International Journal of Pharmaceutics: X
Volume 11
Publication status Published - Jun-2026
ISBN ISSN: 2590-1567.